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Abstract Africa is a continent with a large burden of both infectious and non-communicable diseases. If we are
to move forward as a continent, we need to equip our growing cadre of exceptional young scientists
with the skills needed to tackle the diseases endemic to this continent. For this, immunology is among
the key disciplines. Africans should be empowered to study and understand the diseases that affect
them, and to perform their cutting-edge research in their country of origin. This requires a
multifaceted approach, with buy-in from funders, overseas partners and perhaps, most important of
all, African governments themselves.
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Introduction
In many areas, Africa has been described as the ‘Conti-
nent of the Future’. Yet despite this optimism, there
remains a large disease burden throughout the continent,
exacerbated by poor health systems and a lack of exper-
tise in critical areas [1–3]. A good scientific base, in
which African scientists can tackle the diseases that affect
their communities, is critical to Africa’s development [4,
5]. External scientific expertise and funding are not sus-
tainable resources to address Africa’s problems. Identify-
ing the scientific needs and supporting the best young
Africans to develop the tools necessary for prevention,
diagnosis and treatment of endemic diseases should be a
priority for all African nations.
Understanding the diseases that affect us requires a
multidisciplinary approach. The Holy Grail for many
infectious disease researchers is to find a successful vac-
cine that prevents us from contracting the disease, or
from spreading it to others. Historically, most of our suc-
cessful vaccines have been developed empirically. Finding
a successful vaccine for the many remaining diseases will
require a more rational approach to vaccine design, and
to do this, we need to understand the immunology
behind the disease or infection. Immunological tools are
also important in the development of diagnostics (rapid
tests for HIV and malaria are examples), and sometimes
in therapy. This report discusses the need to further
develop scientific research in Africa from an immunologi-
cal perspective, identifies key barriers to generating a crit-
ical mass of immunologists who can tackle the burden of
today’s diseases in Africa and describes some of the steps
we have already taken towards this goal.
Immunological expertise is needed in Africa
Immunology is a relatively new discipline, and even
newer to the continent of Africa. The lack of immunolog-
ical expertise across the continent is highlighted by the
continent’s immunological publication outputs (Table 1).
South Africa, the most developed country, is ranked first
in Africa but with an output comparable to Poland, 16th
among European countries (Table 1). Kenya and Uganda
(ranked 2nd and 3rd within Africa) fall well below the
top 20 in terms of European countries (Table 2),
although even European science lags behind that of the
USA in terms of immunological output and impact
(Table 3). Nigeria, Africa’s wealthiest nation [6], is
ranked only 12th among the African nations (Table 1).
Clearly, there is a need to build a stronger immunologi-
cal base across the whole of Africa, so that African scien-
tists can compete for funding at the same level as their
European and USA counterparts. But what are the issues
and bottlenecks that are preventing young Africans from
gaining the immunological knowledge required to estab-
lish themselves as leaders in their own field?
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Issues and bottlenecks
Theoretical Immunology
Taught courses are essential for any discipline, and
immunology is no exception. However, outside of South
Africa, there is no university department devoted exclu-
sively to teaching and research in immunology. As a con-
sequence, medical and veterinary schools across Africa
teach only very basic immunology as a topic within the
disciplines of Microbiology or Pathology. Recognising
this need, our Capacity Building Programme (www.-
muii.org.ug) set out to build a short course in immunol-
ogy to meet the growing needs of the continent. This
course has been very successful, and we have trained over
300 young scientists in both theoretical and practical
immunology, with extremely good feedback (Box 1). Our
programme supports undergraduates, postgraduates, post-
docs and university lecturers. Building on the success of
our Programme, the Department of Medical Microbiol-
ogy within the College of Health Sciences at Makerere
University (Uganda) has recently proposed a new Depart-
ment of Immunology. This Department, when inaugu-
rated, will house the MSc in Immunology and Clinical
Microbiology, which has recently been developed (http://
mbl.mak.ac.ug).
Despite our recent success, there are still challenges in
delivering appropriate taught content because there are
few trained immunologists to give expert and in-depth
foundation lectures. We have sought to address this by
bringing together, in Uganda, the leading health research
organisation (The Uganda Virus Research Institute;
Table 1 Immunology output of the top 20 African countries
(1996–2013). Output ranked on H index, a measure of impact
from the research output. Data obtained from SCImago Journal
& Country Rank (http://www.scimagojr.com), accessed 13 April
2015. Data are from the Immunology and Microbiology section
from SCImago
Rank Country
Citable
documents Citations
Citations
per
document
H
index
1 South
Africa
7453 134758 20.74 121
2 Kenya 2843 60503 24.26 90
3 Uganda 1357 26664 24.87 70
4 Tanzania 1426 27283 22.63 65
5 Senegal 1071 18570 18.48 62
6 Gambia 548 14073 25.54 60
7 Malawi 602 13620 27.57 56
8 Cameroon 1162 17186 16.76 54
9 Zambia 559 11407 24.38 54
10 Ghana 912 15900 19.67 52
11 Co^te
d’Ivoire
599 10870 18.34 52
12 Nigeria 3686 25983 9.93 51
13 Burkina
Faso
793 14002 21.34 51
14 Tunisia 2022 19852 15.25 49
15 Ethiopia 851 11957 18.11 48
16 Zimbabwe 559 9818 17.95 45
17 Gabon 470 7988 17.82 45
18 Morocco 885 9210 12.48 41
19 Sudan 635 8414 16.75 41
20 Mali 387 6720 21.72 40
Table 3 Immunology output of the USA (1996–2013). Data
obtained from SCImago Journal & Country Rank (http://
www.scimagojr.com), accessed 13 April 2015. Data are from the
Immunology and Microbiology section from SCImago
Rank Country
Citable
documents Citations
Citations per
document
H
index
1 United
States
274951 9621324 35.75 589
Table 2 Immunology output of the top 20 European countries
(1996–2013). Output ranked on H index, a measure of impact
from the research output. Data obtained from SCImago Journal
& Country Rank (http://www.scimagojr.com), accessed 13 April
2015. Data are from the Immunology and Microbiology section
from SCImago
Rank Country
Citable
documents Citations
Citations
per
document
H
index
1 United
Kingdom
79201 2590073 31.88 359
2 Germany 67651 2147660 32.51 353
3 France 54499 1608328 29.03 302
4 Italy 35717 974429 28.41 276
5 Netherlands 28289 962503 34.91 274
6 Switzerland 20141 776740 40.09 271
7 Sweden 19546 589792 30.33 220
8 Spain 30699 703785 24.23 211
9 Belgium 14857 440608 31.3 202
10 Denmark 12282 359960 30.21 188
11 Austria 9562 298973 33.09 185
12 Finland 7726 223800 29.18 158
13 Ireland 5342 157267 33.64 153
14 Norway 6494 185200 29.92 150
15 Greece 4736 105160 24.58 110
16 Russian
Federation
12641 113805 9.11 108
17 Poland 9450 109371 12.5 107
18 Hungary 3983 78230 20.53 105
19 Portugal 5699 104312 22.17 104
20 Czech
Republic
6514 92618 15.13 99
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www.uvri.go.ug) with the leading University (Makerere
University; www.mak.ac.ug). This has allowed the teach-
ing programmes within the University to be enriched by
the expert knowledge within the leading research institu-
tion. In addition, we have equipped several campus sites
with teleconference equipment to broaden the reach of
local research seminars and visiting scientist seminars.
This two-way interaction enables us to reach out to a
wider interest group who may like to attend the seminar
remotely, because they are otherwise unable to attend
due to scheduling conflicts or travel time. Finally, we will
soon begin adding expert international guest lectures to
taught courses at Makerere University, to account for the
lack of expertise in certain areas. We will begin piloting
this with colleagues at Cambridge University, through the
Cambridge-Africa Programme (http://www.cambridge-
africa.cam.ac.uk).
In our experience, students acquire a deeper under-
standing of concepts and cutting-edge advances in the
field if the person teaching them has extensive experience
of the technology, technique or discipline. Didactic teach-
ing, which is often done where immunological expertise
is lacking and where classes are large, is an uninspiring
way of communicating and inhibits interest in the field.
In our experience, students respond best to interactive
teaching, a method of approach that perhaps requires
Box 1 Sample feedback from the MUII Immunology in the Tropics course
The well-organised training delivered in an all inclusive participatory way was highly motivating to me as a
researcher. Lectures, laboratory-based practicals and discussion on hot topics guided by prominent faculty members
were insightful and provided the much needed current knowledge on immunology of malaria and helminths.
Research tools acquired from the iTROP course were helpful in securing a collaborative grant for the purpose of
undertaking seroprevalence survey for Dengue and Chikungunya viruses.
I partly dedicate my recent achievement of a postdoctoral grant award by the Consortium for National Health
Research (CNHR) to iTROP course work for its motivation, provision of current knowledge and immunology prac-
ticals provided.
If anybody has benefited from the training it is me. I have attended two courses, and the training has contributed
a lot to my profession:
It will contribute towards my promotion
Improvement of my area of specialisation
Obtained the latest facts and research avenues in areas such as immunology of malaria and helminths
As a lecturer, I have improved my delivery to my students, both undergraduates and postgraduates.
The materials obtained from the training are quite resourceful for teaching the latest immunology and are my day
to day guide to my teaching notes.
It was a wonderful experience, and made me love more a career in Immunology. Over the course, I was able to
understand the basic and advanced concepts in immunology, current and advanced techniques used in Immunology
assays through lectures, seminars and journal clubs sessions. The lively debate at the help sessions, the audience
Q&A following a stimulating lecture all cultivated my own enthusiasm, research directions and development as a
scientist.
The quality time we spent interacting with world-class immunologists through dedicated revision time and social
events was priceless. The many hours spent with each of us listening to them, and talking with them about our goals
and plans for the future, were incredibly rewarding.
I learnt so much in both trainings and have been able to use most of what I learnt in writing a grant application
focusing on malaria and helminth infections, and also in designing and optimising my laboratory assays. The train-
ing also enabled me interact with trainers and trainees who were an inspiration to me.
This is to express my gratitude for again another opportunity to attend the Immunology in the Tropics course.
Besides the knowledge I acquired through the lectures, my highlight was that I learnt to know the reason behind
each step in a protocol. This has indeed set me in a position to probe for better understanding of the reasons behind
each protocol step, in which way getting better informed and hitting the road to being a better laboratory technolo-
gist/scientist.
This has not left me the same.
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further implementation in many universities on the
African continent.
These challenges are partially mitigated by the many
online resources available for those with an interest in
this field. Companies such as Becton Dickinson (www.bd-
biosciences.com) and ThermoFisher Scientific (www.ther-
mofisher.com; incorporating Life Technologies and
Invitrogen among other companies) offer very good tuto-
rials and online content for the budding immunologist. In
addition, the Federation of African Immunological Soci-
eties (www.faisafrica.com), and more broadly the African
Academy of Sciences (www.aasciences.org) websites can
point interested parties to upcoming immunological con-
ferences and courses, and are well worth visiting. Finally,
Purdue University (www.cyto.purdue.edu) offers a
curated discussion board specifically to address issues on
flow cytometry, the essential tool of the immunologist.
This is not an exhaustive list of online help for the immu-
nologist, but these are among the good websites available
for the student and lecturer alike to visit and gain insight
and inspiration into the field of immunology.
Animal models
In most areas throughout Africa, researchers are devoted
to understanding the human and animal diseases that are
endemic throughout Africa, and this is as it should be.
But an area that is often overlooked is the laboratory ani-
mal models that have contributed a large amount of
knowledge to any field of immunology. Mouse immunol-
ogy (for example) and human immunology are, of course,
very different. But understanding an animal model,
regardless of how imperfect the model is, can help in
understanding the mechanism of the response in humans.
A novel finding in humans can lead to new hypotheses,
but determining the mechanism behind the finding is
often not achievable in human studies. The novel human
finding can be backed up with animal studies to identify
the mechanism, and conversely, mechanistic studies
developed in animals can be tested in human cohorts to
see whether similar responses occur.
Little mouse immunology is taught because there is
simply not the expertise in Africa to teach the animal
models. This needs a deep understanding of the animal
model, and this cannot be achieved through reading
papers or textbooks alone. Hands-on experience is
needed, as well as active research on animal models. Of
course, most countries in Africa do not have the
resources to sustain specific pathogen-free (SPF) animal
research facilities to explore these animal models. At
some point, this needs to happen in Centres of Excellence
across Africa, but the cost of setting up these facilities in
the absence of a critical mass of within-continent
researchers is prohibitively expensive and limiting. Cur-
rently, the International Livestock Research Institute
(www.ilri.org) and the Institute of Primate Research
(www.primateresearch.org) provide examples where ani-
mal research is being conducted on the continent. But
these are few compared with the number of human stud-
ies that are ongoing, and perhaps the best opportunity
we can give our African researchers is the opportunity to
collaborate on research projects involving animal models.
Split-site PhD and postdoctoral studies may be an ideal
way to integrate human and animal model immunology
research.
Practical immunology
Immunological studies are increasingly being performed
on a daily basis across the whole of Africa, and this is
encouraging. However, without the background knowl-
edge of the immunological mechanism(s) behind the test
or experiment, researchers (or more often, technicians)
are often at a loss as to how to rectify the experiment if
it fails. There are many techniques that we, as immunolo-
gists, use. Many of them, such as the ELISA, are cheap
and easy to perform, and require relatively little training.
More and more now, however, complex techniques are
being used, such as multicolour flow cytometry, Lumi-
nex technology and immunofluorescent microscopy. We
must give our young and enterprising immunologists the
capability of understanding the background to the tech-
nique, and not just the protocol itself. We should be
teaching our cadre of young African scientists to ask
‘how’ and ‘why’. To this end, our Capacity Building Pro-
gramme (http://www.muii.org.ug), funded by the Well-
come Trust, runs Practical Immunology modules, aimed
at teaching participants not only new techniques, but also
the mechanisms behind the techniques. This approach
has been very successful in empowering young scientists
to go back to their home laboratories with renewed
enthusiasm and a deeper understanding of the Immunol-
ogy behind the technique (see Box 1 for an example).
Journal clubs
Getting a small group of like-minded individuals to dis-
cuss a relevant published paper is an excellent way of
integrating and synthesising new concepts in the field. All
too often, however, the article that is presented is a small
article specific to the area of interest of the individual
presenting the paper, and with little challenging material
within the actual paper. Challenging articles are avoided
because the background immunology is not present to
4 © 2015 The Authors. Tropical Medicine & International Health published by John Wiley & Sons Ltd.
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either understand the detail of the experiments that have
been performed, or the concept that the paper is putting
forward. This is by no means an ‘Africa-only’ problem.
But it should be incumbent upon all of us to encourage
our young scientists to present challenging papers.
Of course, choosing the best paper is somewhat subjec-
tive and is largely dependent on the skill of the presenter
in getting the concepts and reasoning of the authors
across to the audience. This is a skill that must also be
learnt, and one in which senior colleagues can lead the
way. Perhaps the biggest issue then is having senior fig-
ures within the room to not only present an article, but
also to challenge concepts, to ask questions and to debate
in an informative way. Such a figure can inspire and
encourage our young African generation to move out of
their comfort zone and test themselves with a truly chal-
lenging article. During our immunology short courses,
our students are given challenging papers to read and
present. Our expert international faculty are available to
help with interpretation and explanation of concepts and
figures, and the students on our courses have found this a
truly rewarding experience. Translating this to one’s own
workplace is the obvious challenge, and we must encour-
age our senior colleagues to give back their knowledge
and experience to the young and enthusiastic researcher.
Job market
Common to all scientific disciplines is the question every
university graduate asks: what now? In Western coun-
tries, a vibrant scientific base means that jobs have been
relatively easy to find. In Africa, without the strong scien-
tific base, University graduates wishing to find a research
post in immunology are often left disappointed. When
junior posts do arise, there are often many applications
for a single post. This is a good thing as far as an
employer goes, as you can often find exceptional talent
among the large number of applications. Unfortunately,
the lack of available positions also means much of Africa
is in an employer’s market, which can lead to unethical
and abusive practices, such as requiring staff to work
overtime without additional pay, or minimising annual
leave, for example. More recently, the Wellcome Trust-
funded African Institutions Initiative has provided oppor-
tunities for postdoctoral researchers, and more of these
initiatives should be encouraged.
It is the experience of many of us that good African
researchers are often overwhelmed with teaching and
administrative duties when taking up or pursuing their
academic goals. This has had the unwanted effect that
many Africans are simply unable to keep their research
interests alive unless they can secure dedicated protected
time from their other academic duties to pursue their
research interests. There is also a lack of higher positions
(postdoctoral to Lecturer, and above) in low- and mid-
dle-income countries. Many graduates want to undertake
higher degrees such as an MSc or PhD, but without the
positions to go with a higher degree, postgraduates are
often forced out of the country to find suitable posts. In
addition, obtaining a higher degree often prices them out
of the market because of the lack of senior positions.
Positions advertising for a technologist often attract MSc
graduates, for example. Because we all rely on funding to
do our research, often salaries are capped for the position
advertised. Although you may get an excellent candidate
who holds an MSc, often the salary is such that it is no
longer attractive to postgraduates. Without appropriate
positions in country, they are forced to look abroad for
further work. This contributes to the brain drain of tal-
ented Africans heading abroad to pursue academic
research and to take up senior positions outside of their
home country.
Inviting Biotec companies to establish laboratories on
the continent, and investing in young Biotec start-ups,
can also help in preventing the brain drain and opening
up new avenues in the job market. Such companies can
bring economic benefit in terms of investing in clinical
immunology for care and diagnostics. African govern-
ments need to recognise the benefit of research and devel-
opment for the improvement of their own health systems
and economy [5].
Integrating immunology research
A key component for the success of research in Africa
will be embedding good immunological studies into basic
and clinical research, within the framework of a sound
epidemiological background and strong statistical sup-
port. Supporting fellows within this framework allows
them to identify relevant questions and design the most
appropriate study to answer the questions they find most
important.
Within our MUII Programme, and working with other
partners, we have supported fellows in both basic [7–12]
and clinical [13–18] research, underpinning this research
with good epidemiological design and statistical advice
from local and international colleagues. We, and our fel-
lows, have found this an excellent scaffold on which to
build the new generation of African science and
research.
However, all too often the equipment or expertise to
undertake immunological studies in Africa is absent, and
samples are sent abroad for well-funded laboratories to
undertake the essential immunological experiments. This
© 2015 The Authors. Tropical Medicine & International Health published by John Wiley & Sons Ltd. 5
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has left Africans to undertake the fieldwork and epi-
demiological studies alone, and this must stop. Minimis-
ing the shipment of samples outside of the African
country of origin would go some way to ensure that our
overseas collaborating partners invest in the country and
train our African scientists. Many countries within
Africa now require substantial justification to send sam-
ples outside of the country. With well-equipped labora-
tories now present in many countries, and with the
growing expertise, such justification is becoming harder
to obtain. There are two notable exceptions where sam-
ples should be sent abroad: multisite studies and com-
plex studies requiring specialised resources, such as high-
throughput sequencing. For multisite studies, it can be
essential that a single laboratory (but not necessarily a
laboratory outside Africa) perform the majority of the
work, to ensure standardised protocols and harmony
across all sites. For complex studies requiring specialised
equipment (such as genomic assays), it may not make
economic sense to have expensive equipment in country:
indeed, researchers all over the world currently out-
source such work to a small number of internationally
well-recognised centres. In such cases, outsourcing to a
specialised laboratory that routinely runs the technique
of interest is a far cheaper and effective way of under-
taking complex research. Here, the critical capacity that
must be built for African scientists is the ability to anal-
yse complex ‘big data’.
Conclusion
So what are the solutions, as we see them? Below we out-
line a few key areas that we believe need to be strength-
ened in order for Africans to develop solutions to their
own infectious disease burdens.
• establish immunology departments with a mix of
expertise, and people with research knowledge to
deliver lectures;
• in the short to medium term, harness local expertise
from research institutes, and international expertise
from collaborating partners, to support the long-term
development of local critical mass;
• develop curricula for structured, taught courses,
including techniques used in both human and mouse
immunology;
• establish teaching laboratories for the delivery of
practical courses to allow students to synthesise the
taught material into hands-on learning;
• integrate epidemiology and statistics into advanced
degrees so that students can better understand the
causes and associations of disease;
• provide pathways to attract the most talented
Africans back to their home country, and long-term
support for them in their country;
• research partnerships between Western and African
Universities, as equal partners;
• minimise the transfer of biological samples outside
of the country of origin, and encourage Western col-
laborators to invest in people and technology within
the country of origin;
• African Governments to recognise the need and posi-
tive impact research and development can have on
society and allocate funds, however small, for
research and development, in their annual budgets.
We are at a turning point in Africa. Countries are
emerging from poverty and the time is now right to con-
sider investing in science, for the continued development
and growth of the continent. We need to invest in the
young scientific generation, and bring back the many tal-
ented Africans who are working outside this continent
due to a lack of funding and infrastructure. Africans
should be empowered to research and understand the dis-
eases that affect them and to perform their cutting-edge
research in their country of origin. This requires a multi-
faceted approach, with buy-in from funders, overseas
partners and perhaps, most important of all, African gov-
ernments themselves.
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